Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Early versus delayed complete revascularisation in patients presenting with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis of randomised controlled trials.

Authors:
Khaled Abouelmagd Hesham Tayel Ashraf Atta Andrew Ladwiniec Mokhtar Ibrahim

Open Heart 2022 Jun;9(1)

Cardiology Department, University Hospitals of Leicester NHS Trust, Leicester, UK

Background: Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.

Objective: The aim of this systematic review and meta-analysis was to assess the effect of timing of complete revascularisation on cardiovascular outcomes in patients with STEMI and multivessel coronary artery disease.

Methods: Searches of PubMed, the Cochrane Library, ClinicalTrials.gov and the reference lists of relevant papers were conducted covering the period from 2004 to 2019. A pairwise analysis was performed to compare the difference in clinical outcome between early complete revascularisation (index procedure or index hospitalisation) and delayed complete revascularisation (after discharge) in patients with STEMI.The primary endpoint was the incidence of major adverse cardiac events (MACE), which was defined as the composite of all-cause mortality, recurrent myocardial infarction, unplanned repeated revascularisation and cardiovascular death.

Results: Twelve studies including a total of 7596 patients were identified. The MACE rate was 10.37% in early complete revascularisation compared with 18.17% in culprit only (p=0.01). When complete revascularisation was delayed, the MACE rate was 11.81% after complete revascularisation compared with 17.21% in culprit-only percutaneous coronary intervention (PCI) (p=0.01). A meta-regression analysis demonstrated no relationship between timing of complete revascularisation and reduction in MACE relative to culprit-only PCI (p=0.862).

Conclusion: In patients with STEMI treated by primary PCI and multivessel disease, there is a benefit of complete revascularisation over culprit-only PCI whether non-culprit revascularisation is performed early in hospital or delayed as an elective procedure. We have not demonstrated a relationship between timing of complete revascularisation and MACE.

Prospero Registration Number: CRD42021226789.

Download full-text PDF

Source
http://dx.doi.org/10.1136/openhrt-2022-001975DOI Listing
June 2022

Publication Analysis

Top Keywords

complete revascularisation
44
revascularisation
14
myocardial infarction
12
timing complete
12
complete
11
elevation myocardial
8
culprit-only pci
8
mace rate
8
patients stemi
8
review meta-analysis
8
systematic review
8
revascularisation cardiovascular
8
outcomes patients
8
multivessel disease
8
stemi multivessel
8
relationship timing
8
revascularisation compared
8
multivessel coronary
8
early complete
8
delayed complete
8

Keyword Occurance

Similar Publications

Acute limb ischaemia due to thrombosed persistent sciatic artery aneurysm presents a surgical challenge in a frail octogenarian.

Authors:
Megan Power Foley Mahmoud Alawy Muhammad Tubassam

Vascular 2022 Jun 23:17085381221111016. Epub 2022 Jun 23.

Department of Vascular Surgery, 58040University College Hospital Galway, Galway, Ireland.

Objectives: Persistent sciatic artery (PSA) is a rare congenital anomaly, whereby the embryonic sciatic artery remains patent with associated degrees of femoral axis hypoplasia. Aneurysmal degeneration and distal ischaemia from thromboembolic complications are common. Revascularisation strategies include embolectomy, bypass or interposition grafting and catheter-directed thrombolysis. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Early versus delayed complete revascularisation in patients presenting with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis of randomised controlled trials.

Authors:
Khaled Abouelmagd Hesham Tayel Ashraf Atta Andrew Ladwiniec Mokhtar Ibrahim

Open Heart 2022 Jun;9(1)

Cardiology Department, University Hospitals of Leicester NHS Trust, Leicester, UK

Background: Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.

Objective: The aim of this systematic review and meta-analysis was to assess the effect of timing of complete revascularisation on cardiovascular outcomes in patients with STEMI and multivessel coronary artery disease. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Complete anatomic surgical myocardial revascularisation during postinfarction ventricular septal defect and ventricular aneurysm repair is associated with improved short- and long-term outcomes.

Authors:
Andrei M Belyaev Ivan I Skopin Galina V Lobacheva Mikhail D Alshibaya

J Card Surg 2022 Jun 11. Epub 2022 Jun 11.

Department of Surgical Treatment of Ischemic Heart Disease, Bakoulev's National Medical Research Centre for Cardiac Surgery, Moscow, Russia.

Background: Coronary artery bypass grafting (CABG) is recommended during acute postinfarction ventricular septal defect (PIVSD) repair, but clinical benefits of surgical revascularization in patients with subacute PIVSD have not been established. We aimed to evaluate the association of primary complete anatomic surgical myocardial revascularization (CASMR) during PIVSD and ventricular aneurysm (VA) repair on patients' short- and long-term outcomes.

Methods: This was a retrospective observational study. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Feasibility of the Complete Endovascular Reconstruction of the Trifurcation (CERT) Technique for Revascularisation in Chronic Limb Threatening Ischemia.

Authors:
Jens Carsten Ritter Uyen Giao Vo Jana-Lee Moss

Vasc Endovascular Surg 2022 Jun 2:15385744221106275. Epub 2022 Jun 2.

Department of Vascular and Endovascular Surgery, 418838Fiona Stanley Hospital, Perth, WA, Australia.

BackgroundRevascularisation of patients with chronic limb threatening ischaemia due to arterial lesions in the below the knee segment can be challenging. This study describes a novel technique that allows a complete endovascular reconstruction of the trifurcation (CERT) utilising stents in the below the knee segment when conventional techniques are exhausted, or have failed to deliver an acceptable result, leading to remaining outflow compromise. Eight patients with Rutherford 5 chronic limb threatening ischaemia underwent CERT between January 1, 2018 and January 1, 2020. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Immediate versus staged revascularisation of non-culprit arteries in patients with acute coronary syndrome: a systematic review and meta-analysis.

Authors:
P A Vriesendorp J M Wilschut R Diletti J Daemen I Kardys F Zijlstra N M Van Mieghem J Bennett G Esposito M Sabate W K den Dekker

Neth Heart J 2022 May 10. Epub 2022 May 10.

Department of Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap